Actorius Innovations And Research Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
as on 03-07-2024
- Paid Up Capital ₹ 0.16 M
as on 03-07-2024
- Company Age 11 Year, 2 Months
- Last Filing with ROC 31 Mar 2023
- Revenue -32.77%
(FY 2023)
- Profit -259.44%
(FY 2023)
- Ebitda -513.23%
(FY 2023)
- Net Worth -7.61%
(FY 2023)
- Total Assets -2.74%
(FY 2023)
About Actorius Innovations And Research
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.16 M, as per Ministry of Corporate Affairs (MCA) records.
Rakshit Kamble, Jayant Khandare, and Aravindan Vasudevan serve as directors at the Company.
- CIN/LLPIN
U73100MH2013PTC246961
- Company No.
246961
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
14 Aug 2013
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media
Who are the key members and board of directors at Actorius Innovations And Research?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Jayant Khandare  | Director | 14-Aug-2013 | Current |
| Aravindan Vasudevan | Director | 14-Aug-2013 | Current |
Rakshit Kamble  | Director | 15-Sep-2020 | Current |
Financial Performance and Corporate Structure Insights of Actorius Innovations And Research.
Actorius Innovations And Research Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 32.77% decrease. The company also saw a substantial fall in profitability, with a 259.44% decrease in profit. The company's net worth dipped by a decrease of 7.61%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Actorius Innovations And Research?
In 2023, Actorius Innovations And Research had a promoter holding of 95.17% and a public holding of 4.83%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Admatius Innovations Private Limited
Active 3 years 30 daysRakshit Kamble and Jayant Khandare are mutual person
Precision Oncology Foundation
Active 2 years 1 monthJayant Khandare and Aravindan Vasudevan are mutual person
Solutions In Innovative Research Private Limited
Active 9 years 4 monthsJayant Khandare is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Actorius Innovations And Research?
Unlock and access historical data on people associated with Actorius Innovations And Research, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Actorius Innovations And Research, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Actorius Innovations And Research's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
